Intrinsic Value of S&P & Nasdaq Contact Us

Alumis Inc. Common Stock ALMS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$38.44
+67.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Alumis Inc. Common Stock (ALMS) has a negative trailing P/E of -9.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 24.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -10.11%, forward earnings yield 4.06%.

Criteria proven by this page:

  • VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 24.7 — analysts expect a return to profitability with estimated EPS of $0.93 for FY2030.
  • Trailing Earnings Yield -10.11% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.06% as earnings recover.
  • Analyst consensus target $38.44 (+67.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ALMS

Valuation Multiples
P/E (TTM)-9.9
Forward P/E24.7
PEG RatioN/A
Forward PEGN/A
P/B Ratio7.99
P/S Ratio117.66
EV/EBITDA-6.7
Per Share Data
EPS (TTM)$-2.32
Forward EPS (Est.)$0.93
Book Value / Share$2.88
Revenue / Share$0.23
FCF / Share$-3.54
Yields & Fair Value
Earnings Yield-10.11%
Forward Earnings Yield4.06%
Dividend Yield0.00%
Analyst Target$38.44 (+67.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2022 -0.9 0.00 -0.51 0.00 -
2023 -4.4 0.06 -2.03 0.00 -
2024 -0.8 0.00 0.86 0.00 -
2025 -34.1 0.47 27.54 345.07 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2022 $-14.93 $0.00 $-111.93M -
2023 $-2.99 $0.00 $-154.99M -
2024 $-10.38 $0.00 $-294.23M -
2025 $-2.86 $24.05M $-243.33M -1011.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-2.95 $-3.64 – $-2.66 $7.89M $6.02M – $10.03M 7
2027 $-2.83 $-3.52 – $-2.47 $31.57M $17M – $44.13M 6
2028 $-2.01 $-2.94 – $-1.09 $172.5M $172.22M – $172.77M 7
2029 $-0.96 $-1.42 – $-0.45 $422.24M $249.92M – $577.39M 2
2030 $0.93 $0.44 – $1.37 $840.35M $497.4M – $1.15B 5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message